Skip to main content

Table 2 Patients' Diagnoses and Treatments

From: A phase I/II trial of beta-(1,3)/(1,6) D-glucan in the treatment of patients with advanced malignancies receiving chemotherapy

Patient #

Diagnosis

Treatment

1

non-small cell lung cancer

carboplatin/taxol

2

pancreatic carcinoma

VP-16/gemzar

3

breast carcinoma

carboplatin/taxotere

4

breast carcinoma

adriamycin/taxotere

5

non-small cell lung cancer

carboplatin/taxol

6

non-small cell lung cancer

carboplatin/taxol

7

small cell lung cancer

VP-16/cisplatin

8

colon cancer

5 FU/leukovorin/oxaliplatin

9

breast cancer

adriamycin/taxotere

10

breast cancer

carboplatin/taxol

11

follicular lymphoma

cytoxan/vincristine/prednisone

12

renal cell carcinoma

cytoxan/nexavar

13

chondrosarcoma

cytoxan/adriamycin/ifosphamide

14

colon cancer

5 FU/leukovorin/oxaliplatin

15

breast cancer

adriamycin/taxotere

16

follicular lymphoma

cytoxan/vincristine/prednisone

17

chronic lymphocytic leukemia

alkeran/prednisone

18

chronic lymphocytic leukemia

alkeran/prednisone

19

pancreatic carcinoma

doxorubicin/gemzar

20

myelodysplastic syndrome

hydroxyurea